Table 5.
Outcome, RSV Genomic Load Tertilea | RSV-A |
RSV-B |
||||||
---|---|---|---|---|---|---|---|---|
Unadjusted Modelb |
Adjusted Modelc |
Unadjusted Modelb |
Adjusted Modelc |
|||||
OR (95% CI) | P Value | OR (95% CI) | P Value | OR (95% CI) | P Value | OR (95% CI) | P Value | |
LOS ≥3 d | ||||||||
Low | Reference | Reference | Reference | Reference | ||||
Intermediate | 1.33 (1.02–1.73) | .04 | 1.32 (.97–1.80) | .08 | 1.54 (1.14–2.07) | .004 | 1.57 (1.09–2.26) | .02 |
High | 1.41 (1.05–1.91) | .03 | 1.47 (1.02–2.10) | .04 | 1.77 (1.24–2.52) | .002 | 1.85 (1.32–2.58) | <.001 |
Intensive care use | ||||||||
Low | Reference | Reference | Reference | Reference | ||||
Intermediate | 0.93 (.73–1.19) | .57 | 0.89 (.66–1.20) | .44 | 1.31 (.82–2.12) | .26 | 1.39 (.82–2.36) | .22 |
High | 1.15 (.90–1.45) | .26 | 1.09 (.81–1.47) | .57 | 2.13 (1.16–3.93) | .02 | 2.12 (1.05–4.27) | .04 |
Abbreviations: CI, confidence interval; LOS, length of hospital stay; OR, odds ratio.
a Threshold cycle tertiles for RSV genomic loads were defined as follows: low, ≥24.3; intermediate, 20.8–24.2; and high, <20.8.
b Unadjusted model controlling for clustering of patients within the sites, using the generalized estimating equations.
c Multivariable model controlling for 10 patient-level variables (age, sex, race/ethnicity, gestational age, maternal smoking during pregnancy, history of wheezing, history of eczema, comorbid medical disorder, duration of difficulty breathing before hospitalization, and viral coinfection status [RSV plus rhinovirus and RSV plus nonrhinovirus pathogens]) and clustering of patients within the sites.